srch

Advances in Therapy is a monthly peer-reviewed medical journal covering clinical medicine, especially research on pharmaceuticals.

Jan 07, 2022 · Advances in Therapy is an international, open choice, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad, covering the use of therapies, devices, and surgical techniques across all therapy areas. The key features of the journal are:

20.12.2021 · Advances in Therapy of Analyses of Patient-Perceived Meaningfulness of Improvement in Symptom Reduction for Overactive Bladder Patients Treated with GEMTESA ® (vibegron) 75 mg

Volume 32 January - December 2015. December 2015, issue 12. November 2015, issue 11. October 2015, issue 10. October 2015, issue 1. How Serotonin is Related with Lower Urinary Dysfunction. This is a supplement. September 2015, issue 9. August 2015, issue 8.

02.01.2022 · The Advances in Therapy Impact Factor IF measures the average number of citations received in a particular year (2021) by papers published in the Advances in Therapy during the two preceding years (2019-2020).

advances in therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions …

07.01.2022 · Advances in Therapy is an international, open choice, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad, covering the use of therapies, devices, and surgical techniques across all therapy areas. The key features of the journal are:

09.11.2021 · Despite numerous advances in treatments over the past decade, non-small cell lung cancer (NSCLC) remains an incurable disease for most patients. The optimal treatment for all patients with locally advanced, but surgically resectable, NSCLC contains at least chemoradiation.

Advances in Therapy is the definitive rapid-publication journal for authors who want to disseminate their work to a worldwide audience as quickly as possible.

advances in therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions …

Advances in Therapy is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q1); Pharmacology (medical) ( ...

advances in therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions …

Advances in Therapy is an international peer reviewed journal dedicated to the rapid publication of studies in clinical medicine, including research on existing drugs and drugs in development...

advances in therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions …

Advances in Therapy is an international peer reviewed journal dedicated to the rapid publication of studies in clinical medicine, including research on ...

advances in therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions …

03.01.2022 · Online first articles listing for Advances in Therapy. Individualized HbA 1c Goals, and Patient Awareness and Attainment of Goals in Type 2 Diabetes Mellitus: A Real-World Multinational Survey Authors (first, second and last of 10)

Journal Impact IF Ranking. · In the Pharmacology (medical) research field, the Quartile of Advances in Therapy is Q1. Advances in Therapy has been ranked ...

Advances in Therapy is an international, open choice, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad, ...

Advances in Therapy ; 2020/2021, -, 3.845 ; 2019, -, 3.871 ; 2018, -, 3.260 ; 2017, -, 3.085 ...

The journal is read by a global audience and receives submissions from all over the world. Advances in Therapy will consider all scientifically sound research ...

Advances in Therapy is a monthly peer-reviewed medical journal covering clinical medicine, especially research on pharmaceuticals. The Managing Editor is Clare Shepherd. The journal publishes original clinical research papers and review articles. The journal was established in 1984 and published by Health Communications. Since 2008 it has been published by Springer Science+Business Media.

Advances in Therapy. Journal home; Submission guidelines; Submission guidelines. Links and downloads Instructions for Authors (Download pdf, 986 kB) Author Information - Guidelines for digital features and plain language summaries (Download pdf, 1.3 MB) Open access publishing.